SZodixStudyAcademic Library

Dashboard Shelves Open access My library Inbox Notes Write Learn Alerts

More

Ask your library Notifications Quick cite Review

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder · Study

ArticleShelves

ArticleEffects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder

Michael H. Bloch2012

OA

Articlegreen2012

Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder

Michael H. Bloch · Suzanne Wasylink · Angeli Landeros‐Weisenberger · Kaitlyn E. Panza · Eileen Billingslea · James Frederick Leckman +4 more

162 citations·0/0 files stored·Biological Psychiatry

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Obsessive-Compulsive Spectrum Disorders Treatment of Major Depression Electroconvulsive Therapy Studies

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 162 citations exist upstream.

References

1976ECDEU Assessment Manual for Psychopharmacology 1967Development of a Rating Scale for Primary Depressive Illness 1989The Yale-Brown Obsessive Compulsive Scale 1989The Yale-Brown Obsessive Compulsive Scale 1984Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites 1994The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency 2004Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder 2006A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

Cited by

2020Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders 2015Obsessive–compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults 2018Neuroscientifically Informed Formulation and Treatment Planning for Patients With Obsessive-Compulsive Disorder 2014The neurobiological link between OCD and ADHD 2016

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2010A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorderarticle · 11 shared references 2012Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled studyarticle · 11 shared references 2006Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorderreview · 10 shared references 2009Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorderarticle · 10 shared references 2008Obsessive Compulsive Disorderother · 10 shared references 2009Children with obsessive-compulsive disorder: are they just “little adults”?review · 9 shared references

Details

Year2012

Typearticle

Published2012-07-10

VenueBiological Psychiatry

ISSN-L0006-3223

Languageen

Citations162

Files0 public / 0

ShelfObsessive-Compulsive Spectrum Disorders

Identifiers

doi10.1016/j.biopsych.2012.05.028

openalex_workW2000519244

Links

Imported from OpenAlex (CC0) — nothing here is generated.

N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial

2013Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive–compulsive disorder as an example of overlapping clinical and genetic heterogeneity

2015Assessment and Management of Treatment-Refractory Obsessive-Compulsive Disorder in Children

2022Treatment-resistant OCD: Pharmacotherapies in adults